Vaccinex
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vaccinex generated cash of -$17,234,000, which is more than the previous year. Cash used in financing activities reached the amount of $12,445,000 last year. Net change in cash is therefore -$4,856,000.
Cash Flow
| 2016 | -19.72M | -793K | 16.35M |
|---|---|---|---|
| 2017 | -21.38M | -68K | 23.97M |
| 2018 | -25.27M | -14.24M | 40.95M |
| 2019 | -30.71M | 14.07M | 13.8M |
| 2020 | -28.64M | -290K | 36.75M |
| 2021 | -25.29M | -32K | 23.32M |
| 2022 | -19.07M | -99K | 16.97M |
| 2023 | -17.23M | -67K | 12.44M |
VCNX Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.39M | 8.58M | 10.59M | 2.77M | 5.61M | 4.18M | 1.66M | 5.81M |
Operating activities | ||||||||
Net income | -20.25M | -19.81M | -22.38M | -28.85M | -31.86M | -29.51M | -18.75M | -13.94M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 119K | 207K | 169K | 307K | 249K | 223K | 206K | 178K |
Stock-based compensation expense | 474K | 545K | 541K | 732K | 447K | 0 | 319K | 135K |
| Deferred income tax benefit | 474K | 545K | 541K | 732K | 447K | 0 | 319K | 135K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -786K | -175K | 157K | 741K | -260K | -522K | -13K | -85K |
Inventories | 0 | 0 | 0 | 0 | 0 | 2.02M | -357K | 3.66M |
Accounts payable | 521K | 457K | -2.10M | 122K | 725K | 421K | -555K | 407K |
Cash generated by operating activities | -17.23M | -19.07M | -25.29M | -28.64M | -30.71M | -25.27M | -21.38M | -19.72M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -20.75M | 0 | 0 |
Investments In Property Plant And Equipment | -67K | -99K | -32K | -290K | -78K | -235K | -68K | -793K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -67K | -99K | -32K | -290K | 14.07M | -14.24M | -68K | -793K |
Financing activities | ||||||||
Common Stock Issued | 12.51M | 17.05M | 32.84M | 28.47M | 13.8M | 37.12M | 7.99M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -74K | -75K | -8.54M | -108K | 0 | -5.5M | 3.97M | -800K |
Cash used in financing activities | 12.44M | 16.97M | 23.32M | 36.75M | 13.8M | 40.95M | 23.97M | 16.35M |
Net Change In Cash | -4.85M | -2.19M | -2.00M | 7.82M | -2.84M | 1.43M | 2.51M | -4.15M |
Cash at end of period | 1.53M | 6.39M | 8.58M | 10.59M | 2.77M | 5.61M | 4.18M | 1.66M |
| Data source | Data source | Data source | Data source | Data source | Data source |